These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6581361)

  • 1. Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity.
    Fioretti MC; Bianchi R; Romani L; Bonmassar E
    J Natl Cancer Inst; 1983 Dec; 71(6):1247-51. PubMed ID: 6581361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-mediated antigenic changes in murine leukemia cells: antagonistic effects of quinacrine, an antimutagenic compound.
    Giampietri A; Fioretti MC; Goldin A; Bonmassar E
    J Natl Cancer Inst; 1980 Feb; 64(2):297-301. PubMed ID: 6928222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy.
    Giampietri A; Bonmassar A; Puccetti P; Circolo A; Goldin A; Bonmassar E
    Cancer Res; 1981 Feb; 41(2):681-7. PubMed ID: 7448813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3'-dimethyl-1-triazeno)imidazole-4-carboxamide.
    Contessa AR; Bonmassar A; Giampietri A; Circolo A; Goldin A; Fioretti MC
    Cancer Res; 1981 Jun; 41(6):2476-82. PubMed ID: 7016315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
    Testorelli C; Archetti YL; Aresca P; Del Vecchio L
    Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased immunogenicity of murine lymphoma cells following exposure to gamma rays in vivo.
    Guadagni F; Roselli M; Fuggetta MP; Perno CF; Goldin A; Giuliani A
    Chemioterapia; 1984 Dec; 3(6):358-64. PubMed ID: 6529777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-mediated immunogenic changes of virus-induced leukemia in vivo.
    Houchens DP; Bonmassar E; Gaston MR; Kende M; Goldin A
    Cancer Res; 1976 Apr; 36(4):1347-52. PubMed ID: 1260759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro cytolysis mediated by NK effectors: modification of the susceptibility of the target cell by in vivo treatment with DTIC].
    Migliorati G; Romani L; Fioretti MC
    Boll Soc Ital Biol Sper; 1981 May; 57(9):1024-30. PubMed ID: 7284118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dacarbazine-induced immunogenicity of a murine leukemia is attenuated in cells transfected with mutated K-ras gene.
    Testorelli C; Bussini S; De Filippi R; Marelli O; Orlando L; Greiner JW; Grohmann U; Tentori L; Giuliani A; Bonmassar E; Graziani G
    J Exp Clin Cancer Res; 1997 Mar; 16(1):15-22. PubMed ID: 9148855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
    Hill HZ; Hill GJ
    Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo.
    Romani L; Fioretti MC; Bianchi R; Nardelli B; Bonmassar E
    J Natl Cancer Inst; 1982 May; 68(5):817-22. PubMed ID: 7040772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide.
    Ballerini P; Franchi A; Fuschiotti P; Piccioni D; Bonmassar E
    Cancer Chemother Pharmacol; 1989; 24(6):359-62. PubMed ID: 2791188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine tumor.
    Grohmann U; Puccetti P; Belladonna ML; Fallarino F; Bianchi R; Binaglia L; Sagakuchi K; Mage MG; Appella E; Fioretti MC
    J Immunol; 1995 May; 154(9):4630-41. PubMed ID: 7722315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of murine lymphoma cells treated with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide to NK-mediated cytotoxicity in vitro.
    Romani L; Migliorati G; Bonmassar E; Fioretti MC
    Int J Immunopharmacol; 1983; 5(4):299-306. PubMed ID: 6629590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo.
    Romani L; Fioretti MC; Bonmassar E
    Transplantation; 1979 Sep; 28(3):218-22. PubMed ID: 494379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma.
    Sugimoto Y; Hirakawa Y; Tanaka N; Tahara M; Sato I; Nishimura T; Suzuki H; Tanaka N
    Cancer Res; 1986 Nov; 46(11):5646-8. PubMed ID: 3463416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo characterization of immunogenicity of a mitoxantrone-resistant murine P388 leukemia.
    Fichtner I; Reipert B; Becker M; Lemm M
    In Vivo; 1993; 7(1):73-9. PubMed ID: 8504210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor selection in vivo for reduced sensitivity to natural resistance and natural antibodies.
    Chow DA
    J Natl Cancer Inst; 1984 Feb; 72(2):339-46. PubMed ID: 6582320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo.
    Taramelli D; Romani L; Bonmassar A; Goldin A; Fioretti MC
    Eur J Cancer (1965); 1981 Apr; 17(4):411-20. PubMed ID: 6171429
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines.
    Nicolin A; Canti G; Marelli O; Veronese F; Goldin A
    Cancer Res; 1981 Apr; 41(4):1358-62. PubMed ID: 7011535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.